Craig W. Hendrix

机构：Johns Hopkins University, Johns Hopkins Medicine · ORCID：0000-0002-5696-8665

发表论文 367 篇 · 总被引 24382 次 · h-index 65

代表论文

• Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084 (2025 · Journal of the International AIDS Society · 被引 18)
• Safety, Tolerability, and Pharmacokinetics of Once-Monthly Oral Islatravir: A Phase 2a Study in Participants at Low Risk for Acquiring Human Immunodeficiency Virus Type 1 (2025 · The Journal of Infectious Diseases · 被引 8)
• Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology development (2025 · PLoS ONE · 被引 8)
• Modeling of HIV‐1 prophylactic efficacy and toxicity with islatravir shows non‐superiority for oral dosing, but promise as a subcutaneous implant (2024 · CPT Pharmacometrics & Systems Pharmacology · 被引 8)
• Estimation of Prevention-Effective CAB-LA Concentrations Among Men Who Have Sex With Men (MSM) and Transgender Women (TGW) in HPTN 083 (2025 · The Journal of Infectious Diseases · 被引 3)
• Safety outcomes among infants whose mothers used the dapivirine vaginal ring or oral PrEP during pregnancy (MTN-042/DELIVER): a randomised phase 3b study (2025 · The Lancet HIV · 被引 3)